BioNTech SE - ADR vs FTAI Aviation Ltd — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while FTAI Aviation Ltd trades at $226.98 (market cap $23.17B). The key difference: BioNTech SE - ADR and FTAI Aviation Ltd are close in size by market cap, and FTAI Aviation Ltd pays a 0.89% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | FTAI | |
|---|---|---|
Market Cap | $23.31B | $23.17B |
Sector | Health | Industrials |
52-Week High | $119.34 | $310.04 |
52-Week Low | $83.89 | $140.40 |
Enterprise Value | $6.60B | $26.29B |
Dividend Yield | — | 0.89% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →